BioSpace News Archive

From left: Amylyx Co-founders and Co-CEOs Justin K

FDA

ALS Update: FDA Sets Amylyx Date, Roche and Aquinnah Collaborate

The FDA will evaluate AMX0035, an investigational oral fixed-dose drug intended for people diagnosed with ALS.

February 17, 2022

·

2 min read

·

Vanessa Doctor, RN

Acadia has resubmitted the Nuplazid application.

FDA

Acadia Resubmits Nuplazid for Expansion into Dementia-Related Psychosis

In April 2021, the U.S. Food and Drug Administration issued Acadia a Complete Response Letter (CRL) related to its previous attempt to expand the approved indication for Nuplazid.

February 17, 2022

·

2 min read

·

Alex Keown

Policy

COVID-19 Update: 73% of Americans Likely Immune to Omicron

At this time, 73% of Americans are immune to Omicron, and it could rise to 80% by mid-March. For that and more COVID-19 news, continue reading.

February 17, 2022

·

4 min read

·

Mark Terry

Business

9 Out of 10 Physicians Report Drug Supply Chain Issues

95% of those surveyed agreed that the pandemic showed the vulnerabilities of the medicine supply chain.

February 17, 2022

·

3 min read

·

Hayley Shasteen

Biotech Bay

Synthego Scores $200M to Advance CRISPR “Science at Scale”

The company plans to use the monies raised to create a cell and gene therapy discovery and development ecosystem researchers can use to speed their research.

February 17, 2022

·

3 min read

·

Mark Terry

Biotech Bay

What BioSpace Heard at the BIO CEO & Investor Conference

BioSpace learned that growing functional organs may indeed be possible, and about the role of protein-to-protein interactions in cancer immunotherapy.

February 17, 2022

·

4 min read

·

Gail Dutton

The recent deaths associated with the Aduhelm drug

Drug Development

Additional Deaths of Patients Taking Aduhelm Spark Renewed Concern

It’s not clear if the recent deaths reported in FAERS resulted from the patients taking Aduhelm. This article takes a deep dive into this controversy.

February 17, 2022

·

3 min read

·

Mark Terry

Drug Development

Despite Robust Results, Innovent Cholesterol Drug Could Face U.S. Challenges

By the end of the CREDIT-1 study, patients experienced a significant reduction in low-density lipoprotein cholesterol compared to the placebo group.

February 17, 2022

·

3 min read

·

Hannah Chudleigh

Business

BioSpace Movers & Shakers, Feb. 18

Biopharma and life sciences organizations strengthen their leadership teams and boards with these Movers & Shakers.

February 17, 2022

·

9 min read

·

Alex Keown

Pete Smith, Ph.D., co-founder, president and CSO/C

Business

Startup Remix Inks RNA Collab with Janssen Valued at $1B

The strategic collaboration centers on Remix’s REMaster platform for the discovery and development of small molecule therapies that modulate RNA processing.

February 17, 2022

·

4 min read

·

Alex Keown